• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢硬化性间质瘤:一项临床病理、免疫组织化学、超微结构及细胞遗传学分析,特别关注其脉管系统

Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature.

作者信息

Kawauchi S, Tsuji T, Kaku T, Kamura T, Nakano H, Tsuneyoshi M

机构信息

Second Department of Pathology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

出版信息

Am J Surg Pathol. 1998 Jan;22(1):83-92. doi: 10.1097/00000478-199801000-00011.

DOI:10.1097/00000478-199801000-00011
PMID:9422320
Abstract

Sclerosing stromal tumor (SST) is a rare ovarian neoplasm occurring predominantly in young women and is histologically characterized by cellular heterogeneity, prominent vasculature, and a pseudolobular appearance composed of cellular and hypocellular areas. In the current study, three cases of SST were ultrastructurally examined and the tumors were found to be composed of several kinds of cells, i.e., luteinized thecalike cells, spindle-shaped fibroblastic cells, and primitive mesenchymal cells. These findings thus supported the ovarian stromal origin of SST. Twelve cases of SST also were analyzed immunohistochemically and demonstrated an expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) in the luteinized thecalike cells and its receptor, fms-like tyrosine kinase 1 (flt-1), in capillary to medium-sized blood vessels. Reverse transcription-polymerase chain reaction (RT-PCR) also showed an expression of VPF/VEGF messenger RNA in SSTs. Accordingly, the characteristic vasculature and edema of SSTs were considered to be associated with the expression of VPF/VEGF. In addition, a fluorescence in situ hybridization (FISH) analysis also showed cells with three copy number of chromosome 12 in 13-21% of all examined SST cells, which suggested the presence of chromosome 12 trisomy in SSTs as well as in other ovarian stromal tumors.

摘要

硬化性间质瘤(SST)是一种罕见的卵巢肿瘤,主要发生于年轻女性,其组织学特征为细胞异质性、显著的血管系统以及由细胞丰富区和细胞稀少区组成的假小叶外观。在本研究中,对3例SST进行了超微结构检查,发现肿瘤由几种细胞组成,即黄素化的类卵泡膜细胞、梭形成纤维细胞和原始间充质细胞。这些发现支持了SST起源于卵巢间质。对12例SST还进行了免疫组织化学分析,结果显示黄素化的类卵泡膜细胞表达血管通透因子/血管内皮生长因子(VPF/VEGF),而在毛细血管至中等大小血管中表达其受体——fms样酪氨酸激酶1(flt-1)。逆转录-聚合酶链反应(RT-PCR)也显示SST中存在VPF/VEGF信使核糖核酸表达。因此,SST的特征性血管系统和水肿被认为与VPF/VEGF的表达有关。此外,荧光原位杂交(FISH)分析还显示,在所有检查的SST细胞中,13%至21%的细胞具有三条12号染色体拷贝数,这表明SST以及其他卵巢间质肿瘤中存在12号染色体三体。

相似文献

1
Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature.卵巢硬化性间质瘤:一项临床病理、免疫组织化学、超微结构及细胞遗传学分析,特别关注其脉管系统
Am J Surg Pathol. 1998 Jan;22(1):83-92. doi: 10.1097/00000478-199801000-00011.
2
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.血管内皮生长因子及其受体flt和KDR在卵巢癌中的表达
J Natl Cancer Inst. 1995 Apr 5;87(7):506-16. doi: 10.1093/jnci/87.7.506.
3
A case of a sclerosing stromal ovarian tumor that expresses VEGF.一例表达血管内皮生长因子(VEGF)的卵巢硬化性间质瘤。
J Obstet Gynaecol Res. 2000 Feb;26(1):35-8. doi: 10.1111/j.1447-0756.2000.tb01198.x.
4
Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.血管通透性因子(血管内皮生长因子)及其受体在卵巢交界性肿瘤和恶性肿瘤中的强表达。
Lab Invest. 1996 Jun;74(6):1105-15.
5
Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.血管内皮生长因子及其受体在星形细胞瘤、少突胶质细胞瘤和室管膜瘤间变进展中的表达
Am J Surg Pathol. 1998 Jul;22(7):816-26. doi: 10.1097/00000478-199807000-00004.
6
The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy.月经周期及妊娠早期人卵巢中的血管内皮生长因子/fms样酪氨酸激酶系统
J Clin Endocrinol Metab. 1999 Oct;84(10):3845-51. doi: 10.1210/jcem.84.10.6025.
7
Vascular endothelial growth factor and its receptors in normal human testicular tissue.正常人类睾丸组织中的血管内皮生长因子及其受体
Mol Cell Endocrinol. 1997 Jul 4;131(1):9-20. doi: 10.1016/s0303-7207(97)00082-8.
8
RT in situ PCR for VEGF mRNA in sclerosing stromal tumor.硬化性间质瘤中VEGF mRNA的逆转录原位聚合酶链反应
Am J Surg Pathol. 2000 Jan;24(1):156-7. doi: 10.1097/00000478-200001000-00028.
9
Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.Ets-1转录因子在人类星形细胞瘤中的表达与Fms样酪氨酸激酶-1(Flt-1)/血管内皮生长因子受体-1的合成及新生血管形成相关。
Cancer Res. 1999 Nov 1;59(21):5608-14.
10
Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.含激酶插入结构域受体(一种血管通透性因子/血管内皮生长因子受体)在艾滋病相关卡波西肉瘤和皮肤血管肉瘤中呈强表达。
Am J Pathol. 1996 Apr;148(4):1065-74.

引用本文的文献

1
Relevance of Molecular Pathology for the Diagnosis of Sex Cord-Stromal Tumors of the Ovary: A Narrative Review.分子病理学在卵巢性索间质肿瘤诊断中的相关性:一篇叙述性综述
Cancers (Basel). 2023 Dec 15;15(24):5864. doi: 10.3390/cancers15245864.
2
TFE3 nuclear expression as a novel biomarker of ovarian sclerosing stromal tumors and associated with its histological morphology.TFE3 核表达作为一种新型的卵巢硬化性间质肿瘤标志物,并与其组织形态学相关。
J Ovarian Res. 2023 Aug 1;16(1):152. doi: 10.1186/s13048-023-01241-y.
3
TFE3 is a Novel Biomarker of Ovarian Sclerosing Stromal Tumours.
TFE3是卵巢硬化性间质瘤的一种新型生物标志物。
Res Sq. 2023 Feb 13:rs.3.rs-2563971. doi: 10.21203/rs.3.rs-2563971/v1.
4
Sclerosingstromaltumor of the ovary (report case) N Youssouf, F Watik, S Sabir, H Boufettal, S Mahdaoui, N Samouh Gynecology Department C CHU Ibn Rochd Casablanca.卵巢硬化性间质瘤(病例报告)N·优素福、F·瓦提克、S·萨比尔、H·布费塔尔、S·马赫道伊、N·萨穆赫 卡萨布兰卡伊本·罗什德大学医院妇产科
Int J Surg Case Rep. 2022 Sep;98:107534. doi: 10.1016/j.ijscr.2022.107534. Epub 2022 Aug 23.
5
Sclerosing stromal cell tumor of ovary.卵巢硬化性间质细胞瘤
Med J Armed Forces India. 2018 Oct;74(4):386-389. doi: 10.1016/j.mjafi.2017.09.007. Epub 2017 Dec 2.
6
The value of MRI for differentiating benign from malignant sex cord-stromal tumors of the ovary: emphasis on diffusion-weighted MR imaging.MRI 对卵巢性索-间质肿瘤良恶性鉴别的价值:着重于弥散加权 MR 成像。
J Ovarian Res. 2018 Aug 30;11(1):73. doi: 10.1186/s13048-018-0444-6.
7
CT findings of sclerosing stromal tumor of the ovary: A report of two cases and review of the literature.卵巢硬化性间质瘤的CT表现:两例报告并文献复习
Oncol Lett. 2016 Jun;11(6):3817-3820. doi: 10.3892/ol.2016.4441. Epub 2016 Apr 15.
8
Sclerosing Sromal Tumor of the Ovary in Postmenopausal Women: A Report of Two Cases.绝经后女性卵巢硬化性间质瘤:两例报告
J Menopausal Med. 2015 Aug;21(2):115-9. doi: 10.6118/jmm.2015.21.2.115. Epub 2015 Aug 28.
9
Sex cord-stromal tumors of the ovary: a comprehensive review and update for radiologists.卵巢性索间质肿瘤:放射科医生的全面综述与更新
Diagn Interv Radiol. 2015 Jul-Aug;21(4):277-86. doi: 10.5152/dir.2015.34414.
10
Sclerosing stromal tumor of the ovary treated with 2-incision total laparoscopic cystectomy.采用两切口全腹腔镜囊肿切除术治疗的卵巢硬化性间质瘤。
Int J Surg Case Rep. 2015;9:72-4. doi: 10.1016/j.ijscr.2015.02.002. Epub 2015 Feb 16.